Ocular Therapeutix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OCUL and other ETFs, options, and stocks.

About OCUL

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. 

CEO
Pravin U. Dugel
CEOPravin U. Dugel
Employees
274
Employees274
Headquarters
Bedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded
2006
Founded2006
Employees
274
Employees274

OCUL Key Statistics

Market cap
2.39B
Market cap2.39B
Price-Earnings ratio
-7.81
Price-Earnings ratio-7.81
Dividend yield
Dividend yield
Average volume
2.18M
Average volume2.18M
High today
$11.30
High today$11.30
Low today
$10.78
Low today$10.78
Open price
$10.78
Open price$10.78
Volume
2.28M
Volume2.28M
52 Week high
$13.85
52 Week high$13.85
52 Week low
$5.79
52 Week low$5.79

Stock Snapshot

The current Ocular Therapeutix(OCUL) stock price is $11.28, with a market capitalization of 2.39B. The stock trades at a price-to-earnings (P/E) ratio of -7.81.

As of 2025-11-12, Ocular Therapeutix(OCUL) stock has fluctuated between $10.78 and $11.30. The current price stands at $11.28, placing the stock +4.6% above today's low and -0.2% off the high.

The Ocular Therapeutix(OCUL)'s current trading volume is 2.28M, compared to an average daily volume of 2.18M.

In the last year, Ocular Therapeutix(OCUL) shares hit a 52-week high of $13.85 and a 52-week low of $5.79.

In the last year, Ocular Therapeutix(OCUL) shares hit a 52-week high of $13.85 and a 52-week low of $5.79.

OCUL News

TipRanks 4d
Ocular Therapeutix Executive Cashes In on Stock Sale!

New insider activity at Ocular Therapeutix ( (OCUL) ) has taken place on November 7, 2025. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can he...

TipRanks 5d
Ocular Therapeutix reports inducement grant under Nasdaq listing rule

Ocular Therapeutix (OCUL) granted inducement awards to one newly hired non-executive employee. The award was made as an inducement material to the individual’s...

Analyst ratings

100%

of 13 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own OCUL. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.